- CEMP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $9.2 million.
- CEMP has traded 23,624 shares today.
- CEMP is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in CEMP with the Ticky from Trade-Ideas. See the FREE profile for CEMP NOW at Trade-Ideas More details on CEMP: Cempra, Inc., a clinical-stage pharmaceutical company, focuses on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases in North America. Currently there are 6 analysts that rate Cempra a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Cempra has been 316,400 shares per day over the past 30 days. Cempra has a market cap of $491.3 million and is part of the health care sector and drugs industry. The stock has a beta of 1.29 and a short float of 12% with 4.87 days to cover. Shares are up 10.7% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.